Skip to content
Search

Latest Stories

Lo’s Pharmacy set to launch innovative hub and spoke model

Lo’s Pharmacy, a Yorkshire-based pharmacy chain is adopting a new approach to hub and spoke in a first of a kind model to be used in the UK.

The pharmacy will centralise its repeat prescription dispensing service for original packs with the support of its medication wholesaler.


The independent group, which has 25 NHS community pharmacies across Yorkshire, will install Centred Solution’s Automated FLOWRx Hub product at its central dispensing facility in Wath-Upon-Dearne, South Yorkshire.

But unlike other FLOWRx customers, who pick packs from a robotic dispensing system or internal warehouse, Lo’s Pharmacy will receive patient-specific flow totes directly from their wholesaler which can then be processed by their hub.

This workflow has not been used anywhere else in the country until now and it is a revolutionary approach to hub and spoke dispensing, showing what can be achieved when key players decide to collaborate. It further demonstrates that there are range of variations of hub and spoke models available and accessible to independent and multiple community pharmacies across the UK.

How the solution will work

Branch pharmacies will perform the clinical and accuracy check and transmit a hub order for patients’ prescriptions using FLOWRx Instore directly to Lo’s Pharmacy’s preferred wholesaler. The wholesaler will then process the order and create patient-specific flow totes containing the exact amount of medication for a specific number of patients.

These patient-specific totes, filled with loose medications, will then be delivered to Lo’s Pharmacy hub where the tote will be scanned and then processed through the FLOWRx automatic labelling unit which scans the medication pack, assigns it for the correct patient and then automatically labels the pack. The medication will be processed into allocated patient baskets at a sortation station before being bagged, scanned and placed into branch totes ready to be delivered back to the pharmacy spoke.

Barcode and RFID technology adds additional safety checks to ensure the right pack is processed for the right patient. Any anomalies are flagged by the system and baskets are placed into a quarantine state where they must be checked and cleared by a pharmacist or ACT before they can continue to be processed.

Back at the pharmacy spoke, FLOWRx Instore will be used to process any exceptions that could not be dispensed at the hub, for example fridge items and controlled drugs, before the prescription is then dispensed to the patient.

An exciting new venture

“When we were looking to move to a hub and spoke model we knew we had to find the right workflow for our pharmacy group. We have worked closely with both Centred Solutions and our medication wholesaler to make our vision a reality and we are excited to be the first pharmacy group in the UK to run with this particular hub and spoke model,” said William Kong, Commercial Manager for Lo’s Pharmacy Group.

“We are confident that the hub and spoke model we are putting in place will free up our branch staff from logistical back room tasks so that they have more time to spend at the counter with patients or in the consulting room delivering both NHS and private services,” he said.

Paul O’Hanlon, Managing Director at Centred Solutions said: “It’s great to see Lo’s Pharmacy embracing hub and spoke and implementing a different workflow to our existing customers. No pharmacy is ever the same and so a one-size fits all approach is never going to work. We pride ourselves on having bespoke software and automation available to meet the differing needs of different pharmacy groups. This is yet another example of hub and spoke being a realistic and achievable option for pharmacies of all shapes and sizes.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
New CPCF funding: “This is the best deal community pharmacy has had in a decade”

This new funding settlement marks a significant step forward in addressing the long term underinvestment in community pharmacy, says RPS England chair Tase Oputu

Pharmacy bodies hail new funding settlement as ‘best deal for community pharmacy in a decade’

Pharmacy bodies have welcomed the new funding settlement for community pharmacies, highlighting its potential to enhance patient access to care and medicines while addressing a decade of underinvestment in the sector.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a record £3.073 billion funding package for 2025/26, along with an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less